SBC Medical Group Holdings Inc

SBC Medical Group Holdings Inc(SBC)股票分析

$5.370

+0.091 (+1.70%)收盘时

Loading chart…
最高
5.370
开盘
5.280
成交量加权均价
5.33
成交量
192.17K
市值
—
最低
5.250
成交额
1.02M
企业价值/息税折旧摊销前利润(TTM)
5.33

SBC Medical Group Holdings Incorporated is a management company, which owns, operates, and provides management services to cosmetic treatment centers. The Company is primarily focused on providing comprehensive management services to franchisee clinics, including, but not limited to, advertising and marketing needs across various platforms, staff management, booking reservations for franchisee clinic customers, assistance with franchisee employee housing rentals and facility rentals, construction and design of franchisee clinics, medical equipment and medical consumable's procurement (resale), the provision of cosmetic products to franchisee clinics for resale to clinic customers, licensure of the use of patent-pending and non-patented medical technologies, trademark and brand use, IT software solutions (including but not limited to remote medical consultations), management of the franchisee clinic’s customer rewards program, and payment tools for the franchisee clinics.

AI 分析 of SBC Medical Group Holdings Inc (SBC)

买入

SBC Medical Group Holdings Inc is a good buy right now due to its strong revenue growth of 13% year-over-year in Q2 2026, reaching $49 million, and a low forward P/E ratio of 9.33, suggesting it is undervalued. The main risk is the recent earnings miss with reported EPS of $0.10 against an estimate of $0.12, which could affect investor sentiment.

估值指标

SBC Medical Group Holdings Inc(SBC)当前预期市盈率为 9.33,5 年平均预期市盈率为 4.74。

预期市盈率

高估
5 年均值 P/E
4.74
当前P/E
9.33
高估
8.72
低估
0.76

预期 EV/EBITDA

严重高估
5 年均值 EV/EBITDA
1.05
当前EV/EBITDA
5.33
高估
2.68
低估
-0.59

预期市销率

高估
5 年均值 P/S
1.36
当前P/S
2.78
高估
2.47
低估
0.24

事件时间线

2026-10-22 (ET)

09:30:00

SBC Medical Group Starts Development of Biological Age Test

2026-08-13 (ET)

07:00:00

SBC Medical Reports Q2 Revenue of $49M

2026-05-14 (ET)

06:40:00

SBC Medical Reports Q1 Revenue of $43M, Below Expectations

2026-03-27 (ET)

16:30:00

Major Averages Drop Due to Strait of Hormuz Incidents

12:00:00

Major Averages Decline Amid Middle East Tensions

资讯

SBC 常见问题 —— 由 Alphio AI 解答

SBC Medical Group Holdings Incorporated is a management company, which owns, operates, and provides management services to cosmetic treatment centers. The Company is primarily focused on providing comprehensive management services to franchisee clinics, including, but not limited to, advertising and marketing needs across various platforms, staff management, booking reservations for franchisee clinic customers, assistance with franchisee employee housing rentals and facility rentals, construction and design of franchisee clinics, medical equipment and medical consumable's procurement (resale), the provision of cosmetic products to franchisee clinics for resale to clinic customers, licensure of the use of patent-pending and non-patented medical technologies, trademark and brand use, IT software solutions (including but not limited to remote medical consultations), management of the franchisee clinic’s customer rewards program, and payment tools for the franchisee clinics. It operates in the Industrials sector.

SBC Medical Group Holdings Inc is a good buy right now due to its strong revenue growth of 13% year-over-year in Q2 2026, reaching $49 million, and a low forward P/E ratio of 9.33, suggesting it is undervalued. The main risk is the recent earnings miss with reported EPS of $0.10 against an estimate of $0.12, which could affect investor sentiment.

暂无帖子

注册或登录后参与讨论

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易